학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 8건 | 목록 1~10
Academic Journal
Andreone BJ; Denali Therapeutics, South San Francisco, California, CA, USA.; Przybyla L; Denali Therapeutics, South San Francisco, California, CA, USA. laralynne.przybyla@gmail.com.; Llapashtica C; Denali Therapeutics, South San Francisco, California, CA, USA.; Rana A; Denali Therapeutics, South San Francisco, California, CA, USA.; Davis SS; Denali Therapeutics, South San Francisco, California, CA, USA.; van Lengerich B; Denali Therapeutics, South San Francisco, California, CA, USA.; Lin K; Denali Therapeutics, South San Francisco, California, CA, USA.; Shi J; Denali Therapeutics, South San Francisco, California, CA, USA.; Mei Y; Denali Therapeutics, South San Francisco, California, CA, USA.; Astarita G; Denali Therapeutics, South San Francisco, California, CA, USA.; Di Paolo G; Denali Therapeutics, South San Francisco, California, CA, USA.; Sandmann T; Denali Therapeutics, South San Francisco, California, CA, USA.; Monroe KM; Denali Therapeutics, South San Francisco, California, CA, USA.; Lewcock JW; Denali Therapeutics, South San Francisco, California, CA, USA. lewcock@dnli.com.
Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 9809671 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1726 (Electronic) Linking ISSN: 10976256 NLM ISO Abbreviation: Nat Neurosci Subsets: MEDLINE
Academic Journal
Nugent AA; Denali Therapeutics, South San Francisco, CA 94080, USA.; Lin K; Denali Therapeutics, South San Francisco, CA 94080, USA.; van Lengerich B; Denali Therapeutics, South San Francisco, CA 94080, USA.; Lianoglou S; Denali Therapeutics, South San Francisco, CA 94080, USA.; Przybyla L; Denali Therapeutics, South San Francisco, CA 94080, USA.; Davis SS; Denali Therapeutics, South San Francisco, CA 94080, USA.; Llapashtica C; Denali Therapeutics, South San Francisco, CA 94080, USA.; Wang J; Denali Therapeutics, South San Francisco, CA 94080, USA.; Kim DJ; Denali Therapeutics, South San Francisco, CA 94080, USA.; Xia D; Denali Therapeutics, South San Francisco, CA 94080, USA.; Lucas A; Denali Therapeutics, South San Francisco, CA 94080, USA.; Baskaran S; Denali Therapeutics, South San Francisco, CA 94080, USA.; Haddick PCG; Denali Therapeutics, South San Francisco, CA 94080, USA.; Lenser M; Denali Therapeutics, South San Francisco, CA 94080, USA.; Earr TK; Denali Therapeutics, South San Francisco, CA 94080, USA.; Shi J; Denali Therapeutics, South San Francisco, CA 94080, USA.; Dugas JC; Denali Therapeutics, South San Francisco, CA 94080, USA.; Andreone BJ; Denali Therapeutics, South San Francisco, CA 94080, USA.; Logan T; Denali Therapeutics, South San Francisco, CA 94080, USA.; Solanoy HO; Denali Therapeutics, South San Francisco, CA 94080, USA.; Chen H; Denali Therapeutics, South San Francisco, CA 94080, USA.; Srivastava A; Denali Therapeutics, South San Francisco, CA 94080, USA.; Poda SB; Denali Therapeutics, South San Francisco, CA 94080, USA.; Sanchez PE; Denali Therapeutics, South San Francisco, CA 94080, USA.; Watts RJ; Denali Therapeutics, South San Francisco, CA 94080, USA.; Sandmann T; Denali Therapeutics, South San Francisco, CA 94080, USA.; Astarita G; Denali Therapeutics, South San Francisco, CA 94080, USA.; Lewcock JW; Denali Therapeutics, South San Francisco, CA 94080, USA.; Monroe KM; Denali Therapeutics, South San Francisco, CA 94080, USA. Electronic address: monroe@dnli.com.; Di Paolo G; Denali Therapeutics, South San Francisco, CA 94080, USA. Electronic address: dipaolo@dnli.com.
Publisher: Cell Press Country of Publication: United States NLM ID: 8809320 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4199 (Electronic) Linking ISSN: 08966273 NLM ISO Abbreviation: Neuron Subsets: MEDLINE
Academic Journal
de Jong JO; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.; Llapashtica C; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.; Genestine M; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.; Strauss K; Clinic for Special Children, Strasburg, PA, USA.; Provenzano F; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University, New York, NY, USA.; Sun Y; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Zhu H; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.; Cortese GP; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.; Brundu F; Department of Systems Biology, Columbia University, New York, NY, USA.; Brigatti KW; Clinic for Special Children, Strasburg, PA, USA.; Corneo B; Stem Cell Core Facility, Columbia University, New York, NY, USA.; Migliori B; Tech4Health and Neuroscience Institutes, NYU Langone Health, New York, NY, USA.; Tomer R; Department of Biological Sciences, Columbia University, New York, NY, USA.; Kushner SA; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Department of Psychiatry, Erasmus MC University Medical Center, Rotterdam, The Netherlands.; Kellendonk C; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.; Department of Pharmacology, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Javitch JA; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.; Department of Pharmacology, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Xu B; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA. bx2105@cumc.columbia.edu.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA. bx2105@cumc.columbia.edu.; Markx S; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA. sm2643@cumc.columbia.edu.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA. sm2643@cumc.columbia.edu.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Logan T; Denali Therapeutics, South San Francisco, CA, USA.; Simon MJ; Denali Therapeutics, South San Francisco, CA, USA.; Rana A; Denali Therapeutics, South San Francisco, CA, USA.; Cherf GM; Denali Therapeutics, South San Francisco, CA, USA.; Srivastava A; Denali Therapeutics, South San Francisco, CA, USA.; Davis SS; Denali Therapeutics, South San Francisco, CA, USA.; Low RLY; Denali Therapeutics, South San Francisco, CA, USA.; Chiu CL; Denali Therapeutics, South San Francisco, CA, USA.; Fang M; Denali Therapeutics, South San Francisco, CA, USA.; Huang F; Denali Therapeutics, South San Francisco, CA, USA.; Bhalla A; Denali Therapeutics, South San Francisco, CA, USA.; Llapashtica C; Denali Therapeutics, South San Francisco, CA, USA.; Prorok R; Denali Therapeutics, South San Francisco, CA, USA.; Pizzo ME; Denali Therapeutics, South San Francisco, CA, USA.; Calvert MEK; Denali Therapeutics, South San Francisco, CA, USA.; Sun EW; Denali Therapeutics, South San Francisco, CA, USA.; Hsiao-Nakamoto J; Denali Therapeutics, South San Francisco, CA, USA.; Rajendra Y; Denali Therapeutics, South San Francisco, CA, USA.; Lexa KW; Denali Therapeutics, South San Francisco, CA, USA.; Srivastava DB; Denali Therapeutics, South San Francisco, CA, USA.; van Lengerich B; Denali Therapeutics, South San Francisco, CA, USA.; Wang J; Denali Therapeutics, South San Francisco, CA, USA.; Robles-Colmenares Y; Denali Therapeutics, South San Francisco, CA, USA.; Kim DJ; Denali Therapeutics, South San Francisco, CA, USA.; Duque J; Denali Therapeutics, South San Francisco, CA, USA.; Lenser M; Denali Therapeutics, South San Francisco, CA, USA.; Earr TK; Denali Therapeutics, South San Francisco, CA, USA.; Nguyen H; Denali Therapeutics, South San Francisco, CA, USA.; Chau R; Denali Therapeutics, South San Francisco, CA, USA.; Tsogtbaatar B; Denali Therapeutics, South San Francisco, CA, USA.; Ravi R; Denali Therapeutics, South San Francisco, CA, USA.; Skuja LL; Denali Therapeutics, South San Francisco, CA, USA.; Solanoy H; Denali Therapeutics, South San Francisco, CA, USA.; Rosen HJ; Memory and Aging Center, Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA; On behalf of the ALLFTD investigators.; Boeve BF; On behalf of the ALLFTD investigators; Department of Neurology, College of Medicine, Mayo Clinic, Rochester, MN, USA.; Boxer AL; Memory and Aging Center, Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA; On behalf of the ALLFTD investigators.; Heuer HW; Memory and Aging Center, Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA; On behalf of the ALLFTD investigators.; Dennis MS; Denali Therapeutics, South San Francisco, CA, USA.; Kariolis MS; Denali Therapeutics, South San Francisco, CA, USA.; Monroe KM; Denali Therapeutics, South San Francisco, CA, USA.; Przybyla L; Denali Therapeutics, South San Francisco, CA, USA.; Sanchez PE; Denali Therapeutics, South San Francisco, CA, USA.; Meisner R; Denali Therapeutics, South San Francisco, CA, USA.; Diaz D; Denali Therapeutics, South San Francisco, CA, USA.; Henne KR; Denali Therapeutics, South San Francisco, CA, USA.; Watts RJ; Denali Therapeutics, South San Francisco, CA, USA.; Henry AG; Denali Therapeutics, South San Francisco, CA, USA.; Gunasekaran K; Denali Therapeutics, South San Francisco, CA, USA.; Astarita G; Denali Therapeutics, South San Francisco, CA, USA; Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, DC, USA.; Suh JH; Denali Therapeutics, South San Francisco, CA, USA.; Lewcock JW; Denali Therapeutics, South San Francisco, CA, USA.; DeVos SL; Denali Therapeutics, South San Francisco, CA, USA. Electronic address: devos@dnli.com.; Di Paolo G; Denali Therapeutics, South San Francisco, CA, USA. Electronic address: dipaolo@dnli.com.
Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE
Electronic Resource
de Jong , J O , Llapashtica , C , Genestine , M , Strauss , K , Provenzano , F , Sun , Y , Zhu , H , Cortese , G P , Brundu , F , Brigatti , K W , Corneo , B , Migliori , B , Tomer , R , Kushner , S A , Kellendonk , C , Javitch , J A , Xu , B , Markx , S & Markx , S 2021 , ' Cortical overgrowth in a preclinical forebrain organoid model of CNTNAP2-associated autism spectrum disorder ' , Nature Communications , vol. 12 , no. 1 , 4087 .
검색 결과 제한하기
제한된 항목
[검색어] Llapashtica, C.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어